| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 166.99B | 165.34B | 155.63B | 148.19B | 137.61B | 134.69B |
| Gross Profit | 17.54B | 17.44B | 16.43B | 15.77B | 14.53B | 14.33B |
| EBITDA | 2.91B | 2.96B | 2.72B | 3.21B | 2.91B | 3.36B |
| Net Income | 2.91B | 2.89B | 2.61B | 2.57B | 2.41B | 2.23B |
Balance Sheet | ||||||
| Total Assets | 99.95B | 85.50B | 80.00B | 72.01B | 64.42B | 63.21B |
| Cash, Cash Equivalents and Short-Term Investments | 5.98B | 5.11B | 5.50B | 3.40B | 3.31B | 4.18B |
| Total Debt | 29.93B | 15.06B | 9.41B | 9.54B | 8.16B | 9.06B |
| Total Liabilities | 66.72B | 53.18B | 48.77B | 43.83B | 38.48B | 38.86B |
| Stockholders Equity | 33.23B | 32.32B | 31.22B | 28.16B | 25.92B | 24.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.43B | 2.82B | 1.84B | 1.00M | -2.80B |
| Operating Cash Flow | 0.00 | 2.47B | 3.68B | 2.29B | 1.94B | -939.00M |
| Investing Cash Flow | 0.00 | -7.27B | -316.00M | -2.80B | -710.00M | -1.66B |
| Financing Cash Flow | 0.00 | 4.11B | -1.31B | 618.00M | -1.57B | 2.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥37.65B | 7.75 | ― | 3.59% | 6.91% | 13.17% | |
76 Outperform | ¥216.44B | 14.34 | 8.53% | 2.45% | 5.14% | -10.92% | |
66 Neutral | ¥108.93B | 13.03 | ― | 3.53% | -0.58% | -46.15% | |
66 Neutral | ¥28.67B | 7.72 | ― | 3.90% | 4.79% | 13.71% | |
66 Neutral | ¥129.11B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥6.13B | 4.98 | ― | 4.13% | 2.76% | -10.23% |